Skip to main content
. Author manuscript; available in PMC: 2022 May 19.
Published in final edited form as: Pharmacotherapy. 2022 Feb 21;42(4):298–310. doi: 10.1002/phar.2669

TABLE 4.

Pain relief by dosage (n = 10)

Variable Median (interquartile range) Visit 1 (10-mg intranasal ketamine) Visit 2 (10-mg intravenous ketamine) Visit 3 (30-mg intranasal ketamine) Visit 4 (50-mg intranasal ketamine)
Percentage of maximum pain relief 22.5 (16.6–71.5) 100 (75–100) 65.5 (40–100) 69.25 (50–100)
Time to maximal pain relief (min) 22.5 (15–60) 5 (5–10) 22.5 (10–30) 15 (10–30)
Duration of maximal pain relief (min) 60 (15–120) 20 (10–210) 55 (15–210) 60 (5–210)
Duration of any pain relief (min) 225 (55–235) 235 (235–235) 205 (110–235) 235 (230–235)